These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 3658087)

  • 1. [Plasma levels of cyclosporin 6 hours after its oral administration, T6: key to the surveillance of the treatment].
    Cantarovich F; Bizzolon C; Cantarovich D; Lefrançois N; Dubernard JM; Traeger J
    Nephrologie; 1987; 8(3):111-22. PubMed ID: 3658087
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cyclosporine plasma levels six hours after oral administration. A useful tool for monitoring therapy.
    Cantarovich F; Bizollon C; Cantarovich D; Lefrançois N; Dubernard JM; Traeger J
    Transplantation; 1988 Feb; 45(2):389-94. PubMed ID: 3278433
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Is serum creatinine a reliable expression of an adequate cyclosporine immunosuppression?
    Cantarovich F; Cantarovich D; Suso E; Lefrançois N; Touraine JL; Traeger J
    Clin Nephrol; 1988 Jan; 29(1):9-11. PubMed ID: 3289807
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy and side-effects of cyclosporine dose monitoring with levels 6 h after the morning dose in heart transplant patients.
    Cantarovich M; Besner JG; Fitchett DH; Latter DA
    Clin Transplant; 1997 Oct; 11(5 Pt 1):399-405. PubMed ID: 9361930
    [TBL] [Abstract][Full Text] [Related]  

  • 5. C2 monitoring in maintenance renal transplant recipients: is it worthwhile?
    Midtvedt K; Fauchald P; Bergan S; Høieggen A; Hallan S; Svarstad E; Bergrem H; Eriksen BO; Pfeffer PF; Dalen I; Leivestad T
    Transplantation; 2003 Oct; 76(8):1236-8. PubMed ID: 14578761
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy and safety of tacrolimus compared with cyclosporin A microemulsion in renal transplantation: 2 year follow-up results.
    Krämer BK; Montagnino G; Del Castillo D; Margreiter R; Sperschneider H; Olbricht CJ; Krüger B; Ortuño J; Köhler H; Kunzendorf U; Stummvoll HK; Tabernero JM; Mühlbacher F; Rivero M; Arias M;
    Nephrol Dial Transplant; 2005 May; 20(5):968-73. PubMed ID: 15741208
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Three-years experience with Neoral C2 monitoring adjusted to a target range of 500-600 ng/ml in long-term renal transplant recipients receiving dual immunosuppressive therapy.
    Carstens J
    Scand J Urol Nephrol; 2008; 42(3):286-92. PubMed ID: 18432535
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [A comparative randomized prospective multicenter study of Sandimmune vs Neoral in liver transplantation].
    Roy A; Grant DR; Kneteman NM; Tchervenkov JI; Levy GA; Tan A; Hendricks L
    Ann Chir; 1998; 52(8):716-21. PubMed ID: 9846420
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Is there a therapeutic range for monitoring plasma cyclosporin in renal allograft recipients?
    Ubhi CS; Woodhouse L; Guillou PJ; Giles GR
    Nephrol Dial Transplant; 1988; 3(6):814-9. PubMed ID: 3147426
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A comparison of measured trough levels and abbreviated AUC estimation by limited sampling strategies for monitoring mycophenolic acid exposure in stable heart transplant patients receiving cyclosporin A-containing and cyclosporin A-free immunosuppressive regimens.
    Dösch AO; Ehlermann P; Koch A; Remppis A; Katus HA; Dengler TJ
    Clin Ther; 2006 Jun; 28(6):893-905. PubMed ID: 16860172
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cyclosporine trough concentrations in predicting allograft rejection and renal toxicity up to 12 months after renal transplantation.
    Min DI; Perry PJ; Chen HY; Hunsicker LG
    Pharmacotherapy; 1998; 18(2):282-7. PubMed ID: 9545147
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cyclosporine challenge in the decision of combined kidney-pancreas versus solitary pancreas transplantation.
    Brennan DC; Stratta RJ; Lowell JA; Miller SA; Taylor RJ
    Transplantation; 1994 Jun; 57(11):1606-11. PubMed ID: 8009595
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical outcomes and C2 cyclosporin monitoring in maintenance renal transplant recipients: 1 year follow-up study.
    Marcén R; Villafruela JJ; Pascual J; Teruel JL; Ocaña J; Tenorio MT; Burgos FJ; Ortuño J
    Nephrol Dial Transplant; 2005 Apr; 20(4):803-10. PubMed ID: 15687111
    [TBL] [Abstract][Full Text] [Related]  

  • 14. RIA plasma cyclosporine values six hours after oral administration (T6)--an easy solution to a difficult therapeutic problem: a retrospective and prospective study.
    Cantarovich F; Bizollon C; Cantarovich D; Lefrancois N; Dubernard JM; Mizony Busnardo ME; De Arteaga J; Suso E; Mpio I; Traeger J
    Transplant Proc; 1987 Feb; 19(1 Pt 2):1723-5. PubMed ID: 3274415
    [No Abstract]   [Full Text] [Related]  

  • 15. Long-term results of a prospective randomized study comparing two immunosuppressive regimens, one with and one without CsA, in low-risk renal transplant recipients.
    Grimbert P; Baron C; Fruchaud G; Hemery F; Desvaux D; Buisson C; Chopin D; Dahmane D; Remy P; Pastural M; Abbou C; Weil B; Lang P
    Transpl Int; 2002 Nov; 15(11):550-5. PubMed ID: 12461659
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ten years of treatment with tacrolimus is related to an excellent renal function, allowing monotherapy in a large proportion of cases: unicentric results of the tacrolimus versus cyclosporine A European Multicentric Study in kidney transplant patients.
    Morales JM; Andrés A; Dominguez-Gil B; Arriola M; Gutiérrez MJ; Hernández E; Ortuño T; Praga M
    Transplant Proc; 2005 Nov; 37(9):3738-42. PubMed ID: 16386523
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of gastrointestinal inflammation and age on the pharmacokinetics of oral microemulsion cyclosporin A in the first month after bone marrow transplantation.
    Schultz KR; Nevill TJ; Balshaw RF; Toze CL; Corr T; Currie CJ; Strong DK; Keown PA
    Bone Marrow Transplant; 2000 Sep; 26(5):545-51. PubMed ID: 11019845
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Everolimus and reduced cyclosporine trough levels in maintenance heart transplant recipients.
    Schweiger M; Wasler A; Prenner G; Stiegler P; Stadlbauer V; Schwarz M; Tscheliessnigg K
    Transpl Immunol; 2006 Jun; 16(1):46-51. PubMed ID: 16701176
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Renal function in cardiac transplant recipients: retrospective analysis of 133 consecutive patients in a single center.
    Tinawi M; Miller L; Bastani B
    Clin Transplant; 1997 Feb; 11(1):1-8. PubMed ID: 9067686
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The pharmacokinetics and acute renal effects of oral microemulsion ciclosporin A in normal pigs.
    Cibulskyte D; Pedersen M; Hjelm-Poulsen J; Hansen HE; Madsen M; Mortensen J
    Int Immunopharmacol; 2006 Apr; 6(4):627-34. PubMed ID: 16504926
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.